Skip to content
Home/Companies/Biotech/Forth Therapeutics
FT

Forth Therapeutics

Biotech·Italy·Active·3yr hold

Forth Therapeutics is a healthcare / biotech company, headquartered in Italy.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Forth Therapeutics?

Forth Therapeutics is currently owned by Sofinnova Partners through Sofinnova Biovelocita I (2022 vintage), since 2023. Across its history, Forth Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Biovelocita I · 2022 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQItaly
SectorHealthcare / Biotech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Sofinnova Partners and Old College Capital since 2023.
Co-invest · 2 holders · 2023 · present
Sofinnova Partners
Sofinnova PartnersActive
2023 · present · Sofinnova Biovelocita I · 2022 · Life Sciences VC
MOIC
–
Old College Capital
Old College CapitalActive
2025 · present · Old College Capital LP · 2011 · Evergreen
MOIC
–

More from Sofinnova Biovelocita I

Other portfolio companies in the same fund.

BioClec
Active
BiotechItaly· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings